Human IGF1/IGF/IGF-I ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_000618.5)
Cat. No.: pGMAAV001559
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human IGF1/IGF/IGF-I Adeno-associated virus expression plasmid (ITR-vector) for IGF1 AAV packaging, IGF1 AAV production.The purified Human IGF1/IGF/IGF-I AAV particle serves as an invaluable asset for in-depth in vivo IGF1 studies, mechanism of action (MOA) research, and the evolution of IGF1-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Go to
IGF1/IGF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAAV001559 |
Gene Name | IGF1 |
Accession Number | NM_000618.5 |
Gene ID | 3479 |
Species | Human |
Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
Insert Length | 462 bp |
Gene Alias | IGF,IGF-I,IGFI,MGF |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | TBG |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
Target ID | GM-T60930 |
Target Name | IGF1 |
Gene ID | 3479, 16000, 698444, 24482, 101101237, 610255, 281239, 100034198 |
Gene Symbol and Synonyms | C730016P09Rik,IGF,Igf-1,IGF-I,IGF1,IGFI,IGFIA,MGF |
Uniprot Accession | P05019 |
Uniprot Entry Name | IGF1_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, INN Index, Cytokine Target |
Disease | Prostate Cancer |
Gene Ensembl | ENSG00000017427 |
Target Classification | Not Available |
The protein encoded by this gene is similar to insulin in function and structure and is a member of a family of proteins involved in mediating growth and development. The encoded protein is processed from a precursor, bound by a specific receptor, and secreted. Defects in this gene are a cause of insulin-like growth factor I deficiency. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing to generate mature protein. [provided by RefSeq, Sep 2015]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.